$111.99
Price
$8.7B
Market Cap
—
P/E Ratio
-20.0
Forward P/E
$-5.33
EPS (TTM)
—
Dividend Yield
$943M
Cash
—
Total Debt
72M
Shares Out
$55.53
$113.02
52-Week Range
Institutional Ownership of NUVALENT INC
|
Fund / Manager
Click to search
|
Shares | Value | % of Portfolio | Cost Basis | Est. Return |
|---|---|---|---|---|---|
| No funds currently hold this stock. | |||||
Trading Activity for NUVALENT INC
|
Fund / Manager
Click to search
|
Action | Change | Shares After | Value | Price |
|---|---|---|---|---|---|
| 2022-Q3 | |||||
| SELL | EXIT | — | — | $16.77 | |
| 2022-Q2 | |||||
| SELL | -32.6% | 1.1M | $15M | $10.30 | |
| 2021-Q3 | |||||
| BUY | NEW | 1.6M | $37M | $27.14 | |
Insider Trading for NUVALENT INC
6 Months Insider Sentiment
Buy $0
Sell $72.4M
0
Buys
110
Sells
-72.4M
Net
7
Grants
Largest
$35.4M
E
$3.3M
Shair
$1.7M
Balcom
| Date |
Insider
Click to search
|
Role
Click to search
|
Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jan 07, 2026 | Alexandra Balcom | Chief Financial Officer | GRANT | 17.5K | — | — |
| Jan 07, 2026 | Henry E. Pelish | Chief Scientific Officer | GRANT | 17.5K | — | — |
| Jan 07, 2026 | Deborah Ann Miller | Chief Legal Officer | GRANT | 17.5K | — | — |
| Jan 07, 2026 | Darlene Noci | Chief Development Officer | GRANT | 17.5K | — | — |
| Jan 07, 2026 | Christopher Durant Turner | Chief Medical Officer | GRANT | 17.5K | — | — |
| Jan 07, 2026 | James Richard Porter | President and CEO | GRANT | 46.2K | — | — |
| Jan 06, 2026 | Henry E. Pelish | Chief Scientific Officer | SELL | 1.1K | $96.75 | $107K |
| Jan 06, 2026 | Henry E. Pelish | Chief Scientific Officer | SELL | 189 | $98.40 | $19K |
| Jan 06, 2026 | James Richard Porter | President and CEO | SELL | 675 | $98.40 | $66K |
| Jan 06, 2026 | Darlene Noci | Chief Development Officer | SELL | 225 | $98.40 | $22K |
| Jan 06, 2026 | Alexandra Balcom | Chief Financial Officer | SELL | 225 | $98.40 | $22K |
| Jan 06, 2026 | Alexandra Balcom | Chief Financial Officer | SELL | 1.3K | $96.75 | $128K |
| Jan 06, 2026 | Alexandra Balcom | Chief Financial Officer | SELL | 1.6K | $97.33 | $159K |
| Jan 06, 2026 | James Richard Porter | President and CEO | SELL | 4.9K | $97.33 | $477K |
| Jan 06, 2026 | Darlene Noci | Chief Development Officer | SELL | 1.6K | $97.33 | $159K |
| Jan 06, 2026 | Deborah Ann Miller | Chief Legal Officer | SELL | 1.3K | $97.33 | $130K |
| Jan 06, 2026 | Deborah Ann Miller | Chief Legal Officer | SELL | 1.1K | $96.75 | $104K |
| Jan 06, 2026 | James Richard Porter | President and CEO | SELL | 4.0K | $96.75 | $383K |
| Jan 06, 2026 | Deborah Ann Miller | Chief Legal Officer | SELL | 183 | $98.40 | $18K |
| Jan 06, 2026 | Darlene Noci | Chief Development Officer | SELL | 1.3K | $96.75 | $128K |
| Jan 06, 2026 | Henry E. Pelish | Chief Scientific Officer | SELL | 1.4K | $97.33 | $133K |
| Jan 06, 2026 | Christopher Durant Turner | Chief Medical Officer | SELL | 1.6K | $97.33 | $159K |
| Jan 06, 2026 | Christopher Durant Turner | Chief Medical Officer | SELL | 1.3K | $96.75 | $128K |
| Jan 06, 2026 | Christopher Durant Turner | Chief Medical Officer | SELL | 225 | $98.40 | $22K |
| Jan 05, 2026 | Darlene Noci | Chief Development Officer | SELL | 317 | $98.52 | $31K |
| Jan 05, 2026 | James Richard Porter | President and CEO | SELL | 8.1K | $97.96 | $798K |
| Jan 05, 2026 | James Richard Porter | President and CEO | SELL | 4.7K | $96.85 | $458K |
| Jan 05, 2026 | James Richard Porter | President and CEO | SELL | 3.7K | $96.06 | $353K |
| Jan 05, 2026 | James Richard Porter | President and CEO | SELL | 1.3K | $98.52 | $132K |
| Jan 05, 2026 | Henry E. Pelish | Chief Scientific Officer | SELL | 1.1K | $97.96 | $111K |
| Jan 05, 2026 | Henry E. Pelish | Chief Scientific Officer | SELL | 660 | $96.85 | $64K |
| Jan 05, 2026 | Henry E. Pelish | Chief Scientific Officer | SELL | 513 | $96.06 | $49K |
| Jan 05, 2026 | Henry E. Pelish | Chief Scientific Officer | SELL | 186 | $98.52 | $18K |
| Jan 05, 2026 | Deborah Ann Miller | Chief Legal Officer | SELL | 2.0K | $97.96 | $195K |
| Jan 05, 2026 | Deborah Ann Miller | Chief Legal Officer | SELL | 1.2K | $96.85 | $112K |
| Jan 05, 2026 | Deborah Ann Miller | Chief Legal Officer | SELL | 897 | $96.06 | $86K |
| Jan 05, 2026 | Deborah Ann Miller | Chief Legal Officer | SELL | 326 | $98.52 | $32K |
| Jan 05, 2026 | Alexandra Balcom | Chief Financial Officer | SELL | 317 | $98.52 | $31K |
| Jan 05, 2026 | Alexandra Balcom | Chief Financial Officer | SELL | 871 | $96.06 | $84K |
| Jan 05, 2026 | Alexandra Balcom | Chief Financial Officer | SELL | 1.1K | $96.85 | $108K |
| Jan 05, 2026 | Alexandra Balcom | Chief Financial Officer | SELL | 1.9K | $97.96 | $189K |
| Jan 05, 2026 | Christopher Durant Turner | Chief Medical Officer | SELL | 317 | $98.52 | $31K |
| Jan 05, 2026 | Christopher Durant Turner | Chief Medical Officer | SELL | 871 | $96.06 | $84K |
| Jan 05, 2026 | Christopher Durant Turner | Chief Medical Officer | SELL | 1.1K | $96.85 | $108K |
| Jan 05, 2026 | Christopher Durant Turner | Chief Medical Officer | SELL | 1.9K | $97.96 | $189K |
| Jan 05, 2026 | Darlene Noci | Chief Development Officer | SELL | 1.9K | $97.96 | $189K |
| Jan 05, 2026 | Darlene Noci | Chief Development Officer | SELL | 1.1K | $96.85 | $108K |
| Jan 05, 2026 | Darlene Noci | Chief Development Officer | SELL | 871 | $96.06 | $84K |
| Jan 02, 2026 | Deborah Ann Miller | Chief Legal Officer | SELL | 540 | $101.47 | $55K |
| Jan 02, 2026 | Deborah Ann Miller | Chief Legal Officer | SELL | 4.0K | $100.03 | $401K |
| Jan 02, 2026 | Deborah Ann Miller | Chief Legal Officer | EXERCISE | 10.0K | $18.93 | $189K |
| Jan 02, 2026 | Deborah Ann Miller | Chief Legal Officer | SELL | 5.5K | $100.77 | $550K |
| Dec 30, 2025 | Darlene Noci | Chief Development Officer | SELL | 3.4K | $99.82 | $335K |
| Dec 30, 2025 | Darlene Noci | Chief Development Officer | SELL | 642 | $101.22 | $65K |
| Dec 30, 2025 | Darlene Noci | Chief Development Officer | EXERCISE | 4.0K | $27.85 | $111K |
| Dec 22, 2025 | Henry E. Pelish | Chief Scientific Officer | EXERCISE | 5.1K | $1.08 | $5K |
| Dec 22, 2025 | Alexandra Balcom | Chief Financial Officer | EXERCISE | 34.5K | $1.08 | $37K |
| Dec 19, 2025 | James Richard Porter | President and CEO | EXERCISE | 57.0K | $0.65 | $37K |
| Dec 10, 2025 | Ron Squarer | Director | GRANT | 2.8K | — | — |
| Dec 08, 2025 | Alexandra Balcom | Chief Financial Officer | SELL | 7.0K | $110.31 | $770K |
| Dec 08, 2025 | Alexandra Balcom | Chief Financial Officer | SELL | 100 | $111.32 | $11K |
| Nov 28, 2025 | Darlene Noci | Chief Development Officer | EXERCISE | 4.0K | $27.85 | $111K |
| Nov 28, 2025 | Darlene Noci | Chief Development Officer | SELL | 645 | $107.85 | $70K |
| Nov 28, 2025 | Darlene Noci | Chief Development Officer | SELL | 3.4K | $108.72 | $365K |
| Nov 24, 2025 | Flynn James E | Director, 10% Owner | SELL | 371.3K | $95.44 | $35.4M |
| Nov 24, 2025 | Matthew Shair | Director | SELL | 104 | $107.70 | $11K |
| Nov 24, 2025 | Matthew Shair | Director | SELL | 336 | $110.42 | $37K |
| Nov 24, 2025 | Matthew Shair | Director | SELL | 369 | $107.70 | $40K |
| Nov 24, 2025 | Matthew Shair | Director | SELL | 572 | $109.77 | $63K |
| Nov 24, 2025 | Matthew Shair | Director | SELL | 638 | $108.73 | $69K |
| Nov 24, 2025 | Matthew Shair | Director | SELL | 1.2K | $110.42 | $132K |
| Nov 24, 2025 | Matthew Shair | Director | SELL | 2.0K | $109.77 | $222K |
| Nov 24, 2025 | Matthew Shair | Director | SELL | 2.3K | $108.73 | $246K |
| Nov 18, 2025 | Alexandra Balcom | Chief Financial Officer | SELL | 220 | $103.61 | $23K |
| Nov 18, 2025 | Alexandra Balcom | Chief Financial Officer | EXERCISE | 729 | $72.35 | $53K |
| Nov 18, 2025 | Alexandra Balcom | Chief Financial Officer | SELL | 509 | $104.54 | $53K |
| Nov 17, 2025 | Alexandra Balcom | Chief Financial Officer | SELL | 380 | $103.68 | $39K |
| Nov 17, 2025 | Alexandra Balcom | Chief Financial Officer | SELL | 3.2K | $102.13 | $326K |
| Nov 17, 2025 | Alexandra Balcom | Chief Financial Officer | SELL | 3.3K | $95.12 | $311K |
| Nov 17, 2025 | Deborah Ann Miller | Chief Legal Officer | EXERCISE | 24.2K | $6.89 | $167K |
| Nov 17, 2025 | Deborah Ann Miller | Chief Legal Officer | SELL | 608 | $107.04 | $65K |
| Nov 17, 2025 | Deborah Ann Miller | Chief Legal Officer | SELL | 8.5K | $105.98 | $903K |
| Nov 17, 2025 | Deborah Ann Miller | Chief Legal Officer | SELL | 15.1K | $105.16 | $1.6M |
| Nov 17, 2025 | Alexandra Balcom | Chief Financial Officer | EXERCISE | 6.9K | $6.89 | $47K |
| Nov 17, 2025 | Alexandra Balcom | Chief Financial Officer | SELL | 4.5K | $100.58 | $452K |
| Nov 17, 2025 | Alexandra Balcom | Chief Financial Officer | SELL | 5.1K | $103.27 | $522K |
| Nov 17, 2025 | Alexandra Balcom | Chief Financial Officer | SELL | 3.6K | $93.80 | $339K |
| Nov 17, 2025 | Alexandra Balcom | Chief Financial Officer | EXERCISE | 13.1K | $72.35 | $950K |
| Oct 30, 2025 | Darlene Noci | Chief Development Officer | SELL | 1.1K | $104.21 | $116K |
| Oct 30, 2025 | Darlene Noci | Chief Development Officer | EXERCISE | 4.0K | $27.85 | $111K |
| Oct 30, 2025 | Darlene Noci | Chief Development Officer | SELL | 57 | $98.91 | $6K |
| Oct 30, 2025 | Darlene Noci | Chief Development Officer | SELL | 218 | $104.58 | $23K |
| Oct 30, 2025 | Darlene Noci | Chief Development Officer | SELL | 350 | $100.69 | $35K |
| Oct 30, 2025 | Darlene Noci | Chief Development Officer | SELL | 1.1K | $103.09 | $112K |
| Oct 30, 2025 | Darlene Noci | Chief Development Officer | SELL | 1.2K | $102.07 | $119K |
| Oct 28, 2025 | Matthew Shair | Director | SELL | 9.2K | $100.27 | $918K |
| Oct 28, 2025 | Matthew Shair | Director | SELL | 32.5K | $100.27 | $3.3M |
| Oct 27, 2025 | Matthew Shair | Director | SELL | 4.0K | $100.23 | $406K |
| Oct 27, 2025 | Matthew Shair | Director | SELL | 14.3K | $100.23 | $1.4M |
| Oct 20, 2025 | Deborah Ann Miller | Chief Legal Officer | EXERCISE | 5.0K | $6.89 | $34K |
| Oct 20, 2025 | Deborah Ann Miller | Chief Legal Officer | SELL | 5.0K | $94.91 | $475K |
| Oct 16, 2025 | James Richard Porter | President and CEO | SELL | 700 | $92.63 | $65K |
| Oct 16, 2025 | Deborah Ann Miller | Chief Legal Officer | SELL | 2.3K | $90.54 | $206K |
| Oct 16, 2025 | Deborah Ann Miller | Chief Legal Officer | SELL | 4.9K | $92.50 | $453K |
| Oct 16, 2025 | Deborah Ann Miller | Chief Legal Officer | SELL | 5.2K | $91.37 | $475K |
| Oct 16, 2025 | Deborah Ann Miller | Chief Legal Officer | EXERCISE | 12.4K | $6.89 | $85K |
| Oct 16, 2025 | James Richard Porter | President and CEO | SELL | 13.9K | $90.91 | $1.3M |
| Oct 16, 2025 | James Richard Porter | President and CEO | SELL | 11.3K | $90.01 | $1.0M |
| Oct 16, 2025 | James Richard Porter | President and CEO | SELL | 1.1K | $92.19 | $103K |
| Oct 16, 2025 | James Richard Porter | President and CEO | EXERCISE | 27.0K | $18.93 | $511K |
| Oct 15, 2025 | Deborah Ann Miller | Chief Legal Officer | SELL | 15.6K | $89.98 | $1.4M |
| Oct 15, 2025 | Alexandra Balcom | Chief Financial Officer | SELL | 1.7K | $85.57 | $144K |
| Oct 15, 2025 | Alexandra Balcom | Chief Financial Officer | EXERCISE | 1.7K | $18.93 | $32K |
| Oct 15, 2025 | Deborah Ann Miller | Chief Legal Officer | EXERCISE | 15.6K | $6.89 | $108K |
| Oct 14, 2025 | Alexandra Balcom | Chief Financial Officer | SELL | 5.8K | $86.63 | $504K |
| Oct 14, 2025 | Alexandra Balcom | Chief Financial Officer | SELL | 1.7K | $87.67 | $149K |
| Oct 14, 2025 | Alexandra Balcom | Chief Financial Officer | SELL | 200 | $88.90 | $18K |
| Oct 14, 2025 | Alexandra Balcom | Chief Financial Officer | EXERCISE | 20.0K | $18.93 | $379K |
| Oct 14, 2025 | Henry E. Pelish | Chief Scientific Officer | SELL | 1.2K | $84.98 | $99K |
| Oct 14, 2025 | Henry E. Pelish | Chief Scientific Officer | SELL | 866 | $86.11 | $75K |
| Oct 14, 2025 | Henry E. Pelish | Chief Scientific Officer | SELL | 400 | $87.39 | $35K |
| Oct 14, 2025 | Henry E. Pelish | Chief Scientific Officer | EXERCISE | 877 | $27.85 | $24K |
| Oct 14, 2025 | Henry E. Pelish | Chief Scientific Officer | EXERCISE | 825 | $29.33 | $24K |
| Oct 14, 2025 | Henry E. Pelish | Chief Scientific Officer | EXERCISE | 731 | $18.93 | $14K |
| Oct 14, 2025 | Alexandra Balcom | Chief Financial Officer | SELL | 12.3K | $85.75 | $1.1M |
| Oct 13, 2025 | Alexandra Balcom | Chief Financial Officer | EXERCISE | 13.1K | $18.93 | $248K |
| Oct 13, 2025 | Henry E. Pelish | Chief Scientific Officer | SELL | 7.6K | $89.81 | $686K |
| Oct 13, 2025 | Alexandra Balcom | Chief Financial Officer | EXERCISE | 6.9K | $6.89 | $47K |
| Oct 13, 2025 | Alexandra Balcom | Chief Financial Officer | SELL | 12.3K | $88.73 | $1.1M |
| Oct 13, 2025 | Alexandra Balcom | Chief Financial Officer | SELL | 6.1K | $87.90 | $540K |
| Oct 13, 2025 | Alexandra Balcom | Chief Financial Officer | SELL | 1.6K | $89.22 | $142K |
| Oct 13, 2025 | Henry E. Pelish | Chief Scientific Officer | EXERCISE | 1.7K | $18.93 | $32K |
| Oct 13, 2025 | Henry E. Pelish | Chief Scientific Officer | EXERCISE | 1.8K | $72.35 | $130K |
| Oct 13, 2025 | Henry E. Pelish | Chief Scientific Officer | EXERCISE | 4.2K | $27.85 | $116K |
| Oct 01, 2025 | Alexandra Balcom | Chief Financial Officer | SELL | 19.0K | $85.43 | $1.6M |
| Oct 01, 2025 | Alexandra Balcom | Chief Financial Officer | SELL | 970 | $86.37 | $84K |
| Oct 01, 2025 | Alexandra Balcom | Chief Financial Officer | EXERCISE | 16.8K | $6.89 | $116K |
| Oct 01, 2025 | Alexandra Balcom | Chief Financial Officer | EXERCISE | 3.2K | $18.93 | $61K |
| Sep 30, 2025 | Alexandra Balcom | Chief Financial Officer | EXERCISE | 20.0K | $6.89 | $138K |
| Sep 30, 2025 | Alexandra Balcom | Chief Financial Officer | SELL | 20.0K | $85.06 | $1.7M |
| Sep 29, 2025 | Alexandra Balcom | Chief Financial Officer | EXERCISE | 7.6K | $6.89 | $52K |
| Sep 29, 2025 | Alexandra Balcom | Chief Financial Officer | SELL | 7.6K | $85.01 | $645K |
| Sep 15, 2025 | James Richard Porter | President and CEO | SELL | 2.1K | $80.12 | $168K |
| Sep 15, 2025 | James Richard Porter | President and CEO | SELL | 16.1K | $79.30 | $1.3M |
| Sep 15, 2025 | James Richard Porter | President and CEO | EXERCISE | 27.0K | $18.93 | $511K |
| Sep 15, 2025 | James Richard Porter | President and CEO | SELL | 8.8K | $78.42 | $692K |
| Sep 10, 2025 | Henry E. Pelish | Chief Scientific Officer | EXERCISE | 877 | $27.85 | $24K |
| Sep 10, 2025 | Henry E. Pelish | Chief Scientific Officer | EXERCISE | 731 | $18.93 | $14K |
| Sep 10, 2025 | Henry E. Pelish | Chief Scientific Officer | SELL | 3.7K | $78.83 | $294K |
| Sep 10, 2025 | Henry E. Pelish | Chief Scientific Officer | EXERCISE | 2.1K | $29.33 | $62K |
| Aug 29, 2025 | Henry E. Pelish | Chief Scientific Officer | EXERCISE | 3.0K | $1.08 | $3K |
| Aug 29, 2025 | Henry E. Pelish | Chief Scientific Officer | EXERCISE | 2.0K | $0.87 | $2K |